regression modeling. Results: Of the 338 diabetic patients who met all inclusion criteria, 89 (26.3%) were assigned to the ZDC group and 249 (73.7%) were assigned to the control group. About 60% of the diabetic patients participating in the study were from Quality Blue Primary Care (QBPC) providers. After all model adjustments, the ZDC group showed a positive trend with 11% more members having their hemoglobin A1c less than 8 in the post period than the control group. Diabetic patients participating in the ZDC program in the post-period saw a significant decrease in the following healthcare utilization: all-cause hospital admissions (35/1000), avoidable admissions (17/1000), 15-and 30-day readmission (29/1000; 50/1000), and a significant increase in primary care office visits (166/1000). ConClusions: The ZDC program for diabetic patients is effective in increasing medication adherence and reducing healthcare utilization either in isolation or in conjunction with QBPC providers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.